Kolexia
Borcoman Edith
Oncologie médicale
Clcc Institut Curie
Paris, France
98 Activités
6 Followers

Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Carcinome épidermoïde Carcinomes Carcinome épidermoïde de la tête et du cou Tumeurs de la tête et du cou Tumeurs du sein Métastase tumorale Récidive tumorale locale Tumeurs du col de l'utérus Tumeurs de la bouche

Industries

MSD
2 collaboration(s)
Dernière en 2022
Daiichi Sankyo
2 collaboration(s)
Dernière en 2023
Sandoz
2 collaboration(s)
Dernière en 2022
Amgen
1 collaboration(s)
Dernière en 2020

Dernières activités

Tumor mutational burden assessment and standardized bioinformatics approach using custom NGS panels in clinical routine.
BMC biology   20 février 2024
SHIVA02 - Evaluation of the Efficacy of Targeted Therapy Based on Tumor Molecular Profiling in Patients With Advanced Cancer Using Each Patient as Its Own Control
Essai Clinique (Institut Curie)   15 février 2024
MOST plus: A Two-period, Multicenter, Randomized, Open-label, Phase II Study Evaluating the Clinical Benefit of a Maintenance Treatment Targeting Tumor Molecular Alterations in Patients With Progressive Locally-advanced or Metastatic Solid Tumors
Essai Clinique (Centre Léon-Bérard)   09 février 2024
Randomized phase II study of preoperative afatinib in untreated head and neck cancers: predictive and pharmacodynamic biomarkers of activity.
Scientific reports   18 décembre 2023
BrainStorm: a multicenter international study to tackle CNS metastases in solid tumors.
Nature medicine   19 octobre 2023
115P BrainStorm-NSE: Serum neuron-specific enolase as a biomarker for central nervous system metastases: A prospective cohort study
Molecular Analysis for Precision Oncology Congress 2023 4-6 October 2023   01 octobre 2023
ABLE02: A National, Multicenter, Randomized Controlled Trial to Assess the Efficacy of a Physical Activity Program to Improve Quality of Life and Reduce Fatigue in Women With Metastatic Breast Cancer
Essai Clinique (Centre Léon-Bérard)   29 août 2023
CD39 conventional CD4 T cells with exhaustion traits and cytotoxic potential infiltrate tumors and expand upon CTLA-4 blockade.
Oncoimmunology   18 août 2023
Phase Ib/II of TG4001 and Avelumab in HPV16 Positive R/M Cancers: A Phase Ib/II Trial Evaluating the Combination of TG4001 and Avelumab in Patients With HPV-16 Positive Recurrent or Metastatic Malignancies.
Essai Clinique (Transgene)   01 août 2023
Combined Tumor-Based and Mutation Testing in Ovarian Cancer.
International journal of molecular sciences   18 juillet 2023